Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: A population-based study

Chest

Volumn 147, Issue 1, 2015, Pages 150-156

  Dalleywater, William ^a   Powell, Helen A ^a   Hubbard, Richard B ^a   Navaratnam, Vidya ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC ACID DERIVATIVE; WARFARIN;

AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBROSING ALVEOLITIS; GENDER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; HEALTH SURVEY; IDIOPATHIC PULMONARY FIBROSIS; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY; UNITED KINGDOM;

AGED; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; MALE; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84920719403     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0041     Document Type: Article

References (28)

1. Panos RJ, Mortenson RL, Niccoli SA, King TE Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med. 1990; 88 (4): 396-404.
2. Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. E ur Respir J. 2008; 32 (1): 170-174.
3. Hubbard RB, Smith C, Le Jeune I, Gribbin J, Fogarty AW. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med. 2008; 178 (12): 1257-1261.
4. Ponnuswamy A, Manikandan R, Sabetpour A, Keeping IM, Finnerty JP. Association between ischaemic heart disease and interstitial lung disease: a case-control study. Respir Med. 2009; 103 (4): 503-507.
5. Nathan SD, Basavaraj A, Reichner C, et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. R espir Med. 2010; 104 (7): 1035-1041.
6. Gribbin J, Hubbard R, Smith C. Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. R espir Med. 2009; 103 (6): 927-931.
7. Enomoto T, Usuki J, Azuma A, Nakagawa T, Kudoh S. Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis. C hest. 2003; 123 (6): 2007-2011.
8. Reed RM, Eberlein M, Girgis RE, et al. Coronary artery disease is underdiagnosed and under-treated in advanced lung disease. Am J Med. 2012; 125 : 1228 e1213-1228 e1222.
9. Harris JM, Johnston ID, Rudd R, Taylor AJ, Cullinan P. Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. Thorax. 2010; 65 (1): 70-76.
10. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med. 2000; 161(1): 5-8.
11. The Health Improvement Network. CSD Health Research website. http://www.thin-uk.com. Accessed January 2, 2012.
12. Mapel DW, Hunt WC, Utton R, Baumgartner KB, Samet JM, Coultas DB. Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax. 1998; 53 (6): 469-476.
13. Navaratnam V, Fleming KM, West J, et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax. 2011; 66 (6): 462-467.
14. Navaratnam VFA, McKeever T, Thompson N, et al. Is an increased tendency to clot a risk factor for developing idiopathic pulmonary fibrosis. Thorax. 2012; 67(suppl 2): A48.
15. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med. 2001; 164 (7): 1171-1181.
16. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest. 1998; 113 (2): 396-400.
17. Fell CD, Martinez FJ, Liu LX, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010; 181 (8): 832-837.
18. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006; 61 (11): 980-985.
19. Fernández Pérez ER, Daniels CE, Schroeder DR, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest. 2010; 137 (1): 129-137.
20. Hansell A, Hollowell J, Nichols T, McNiece R, Strachan D. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax. 1999; 54 (5): 413-419.
21. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010; 69 (1): 4-14.
22. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends. 1997 ;(87): 36-40.
23. Kizer JR, Zisman DA, Blumenthal NP, et al. Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med. 2004; 164 (5): 551-556.
24. Izbicki G, Ben-Dor I, Shitrit D, et al. The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor? Respir Med. 2009; 103 (9): 1346-1349.
25. Sode BF, Dahl M, Nielsen SF, Nordestgaard BG. Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study. Am J Respir Crit Care Med. 2010; 181 (10): 1085-1092.
26. Sprunger DB, Olson AL, Huie TJ, et al. Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. Eur Respir J. 2012; 39 (1): 125-132.
27. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994; 88 (3): 601-607.
28. Meade TW, Stirling Y, Thompson SG, et al. An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group. Int J Epidemiol. 1986; 15 (3): 331-336.